Greg Hattoy

Greg brings over 17 years of hands-on leadership in biopharmaceutical manufacturing operations to his role at Alnylam Pharmaceuticals, where he drives operational excellence, audit readiness, and human performance initiatives. His expertise spans deviation investigation, facility operations, and continuous improvement, with a particular focus on translating strategic objectives into actionable floor-level execution. Greg's operator-informed perspective provides valuable insights into facility lifecycle management, performance reliability, and building compliance-driven organizational culture.